Associated Papers
Melanoma-associated mutants within the serine-rich domain of PAK5 direct kinase activity to mitogenic pathways.
LaPak KM et al.
Oncotarget, 2018
Using large-scale genomics data to identify driver mutations in lung cancer: methods and challenges.
Hudson AM et al.
Pharmacogenomics, 2015
Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.
Fawdar S et al.
Proceedings of the National Academy of Sciences of the United States of America, 2013
Select a paper to view details